Raymond James Financial’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$70.3K	Buy	12,212 +1,079	+10%	+$6.22K	﹤0.01%	4984
2025 Q1	$36.5K	Sell	11,133 -480	-4%	-$1.57K	﹤0.01%	4609
2024 Q4	$36.8K	Buy	+11,613	New	+$36.8K	﹤0.01%	4595